Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
CEO Spotlight: Gaston Salinas
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
The Transformative Potential of Gene Therapy
Parenteral Perspectives
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Immunome Promotes Max Rosett to Chief Financial Officer
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Johnson & Johnson Agrees to Acquire Proteologix
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
Galapagos, Blood Centers of America Enter Strategic CAR-T Mfg. Pact
Veeva Systems Introduces Veeva Vault Basics
Examining the Role of AI in Supply Chain Management Across the Bio/Pharma Industry
Scorpius Earns cGMP Facility Validation for Microbial Manufacturing
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Pharma Matters Q&A: PCI Pharma Services
Pharma Matters Q&A: Marken
Parenteral Perspectives
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
Clinical Trial Modernization - Optimizing the Supply of Decentralized Studies
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Advance Microbial Detection with Metagenomic Techniques
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
BMS’s CAR T Cell Therapy Breyanzi Approved for Follicular Lymphoma
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
The Future of Pharmacovigilance is Proactive
Parenteral Perspectives
"3 Key Trends" with Rob Feltz
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
TATAA Biocenter Awarded GLP Accreditation
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Lannett CDMO
TaiMed Biologics
SUANFARMA CDMO
Abzena
AMERIPHARMA
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Lannett CDMO
TaiMed Biologics
SUANFARMA CDMO
Abzena
AMERIPHARMA
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Search Results for '
celgene
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Advanced Degrees
Ask The Board
Ask The Experts
Back Page
Bio News & Views
Blog
Breaking News
Business Corner
Buyers Guide Companies
Case Studies
Classifieds
Columns
Company Blog
Conference Sessions
Content Microsite
Ebook
Editorial
Executive Perspective
Expert's Opinion
FDA Watch
Features
Financial Analysis
Getting Results
Glossary
I Mak
India Report
Industry Events
Infographics
Jobs
Literature / Brochures
Live From Shows
Lowe Down
Managing Your Career
News Releases
Online Exclusives
Outsourcing Survey
Pharma Beat
Podcasts
Posters
Preclinical Outsourcing
Product Releases
Salary Survey
Services
Slideshows
Sponsored Content
Top 25 Pharma & BioPharma
Top Companies Report
Trials & Filings
Videos
Webinars
White Papers / Tech Papers
Celgene
...
Kristin Brooks, Managing Editor
07.15.20
Breaking News
|
Promotions & Moves
ADC Therapeutics Appoints Jennifer Creel as CFO
Former Celgene executive brings deep oncology-focused financial expertise
Contract Pharma Staff
04.21.20
Drug Development
Major Drug Approvals of 2019
Abbvie, Novartis, Pfizer and J&J score big wins with blockbuster potential
Online Exclusives
Kristin Brooks, Contract Pharma
02.24.20
Financial Reports
Financial Report: Bristol-Myers Squibb
Revenue growth in the quarter primarily driven by Celgene acquisition
02.03.20
Breaking News
|
Promotions & Moves
Eisai Expands Leadership Team
Adds two key appointments in the areas of Corporate Affairs and Market Access
02.03.20
Breaking News
|
Collaborations & Alliances
|
Drug Development
Evotec, Bristol-Myers Squibb Expand Alliance
Inclusion of additional cell lines triggers $6 million payment from BMS
01.14.20
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
|
Industry News
Evotec and BMS Expand IPSC Collaboration
Adding cell types supports discovery of disease-modifying therapies for neurodegenerative diseases.
01.07.20
Drug Development
|
Promotions & Moves
Antengene Appoints CBO
John Chin responsible for global business development and commercialization
01.06.20
Drug Development
|
R&D
Top Pharma M&A Deals of 2019
Drug manufacturers spent a record $342 billion on Mergers & Acquisitions
Online Exclusives
Kristin Brooks, Contract Pharma
12.23.19
Breaking News
|
Industry News
Amgen Completes Otezla Acquisition
Otezla is the only oral, non-biologic treatment for plaque psoriasis and psoriatic arthritis
11.21.19
AAPS Exhibitor List
...
10.29.19
Facility of the Future: Advances in Sterile Product Manufacturing
...
10.28.19
Biologics, Proteins, Vaccines
|
Industry News
Ovizio, Celgene Execute Supply Pact
Will use Ovizio's on-line iLine F microscope and the BioConnect system to further automate the manufacturing of engineered T-cell products
10.22.19
Biologics, Proteins, Vaccines
|
cGMP Manufacture
|
Drug Development
Continued and Consistent Investment in Manufacturing Facilities
As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
Ryan Carpentier, Executive Director of Business Development, Cryoport
09.23.19
Industry News
Amgen Acquires Rights to Celgene’s Otezla
Expands inflammation franchise with oral, non-biologic treatment for psoriasis and psoriatic arthritis
08.26.19
Top 25 Pharma and Biopharma Companies
(Based on 2018 Pharma/Biopharma Sales, in $U.S. Millions)
Tim Wright & Kristin Brooks
07.18.19
Top 25 Pharma and Biopharma Companies
...
07.15.19
Celgene
...
07.15.19
The Top Companies Report
Combined sales for 2018 topped the $600 billion mark
Tim Wright, Editor
07.15.19
11 Bristol-Myers Squibb
...
07.11.19
Drug Development
|
Industry News
Evotec, Celgene Expand Strategic Alliance
Expanded neurodegenerative alliance to include a new cell type, triggering $9.0 million payment to Evotec
06.05.19
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
|
Industry News
|
R&D
Celgene Enters AI Drug Discovery Deal with Exscientia
Collaboration focused on accelerating drug discovery in oncology and autoimmunity
03.25.19
Analytical Services
|
APIs
|
Capsules
|
Chemistry
|
Clinical Trial Materials
|
Drug Delivery
|
Drug Development
|
Drug Discovery
|
Excipients
|
Fill/Finish
|
Formulation Development
|
Inspections
|
Microbiology
|
Parenterals
|
Process Development
|
Process Validation
|
Regulatory Affairs
|
Risk Management
|
Supply Chain
|
Validation
|
Vials
Contract Pharma Team
...
02.28.19
Bio News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
Industry News
|
R&D
Triphase Accelerator & Celgene Partner for Cancer
For a first-in-class preclinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia
01.29.19
Bio News
|
Collaborations & Alliances
|
Industry News
Evotec, Celgene Collaboration Reaches Milestone
Resulting in Celgene designating a program and triggering a payment of $ 14M to Evotec
01.08.19
Breaking News
|
Drug Development
|
Industry News
Bristol-Myers Squibb, Celgene Ink $74B Merger
Transaction will create a leading specialty biopharma company in the areas of cancer, inflammatory and immunologic disease and cardiovascular disease
01.03.19
Breaking News
|
Collaborations & Alliances
|
Drug Development
Celgene Licenses Two Dragonfly Immunotherapy Candidates
The licenses represent the first two of four hematological cancer targets from the companies' June 2017 collaboration
12.13.18
Breaking News
|
Drug Development
|
Drug Discovery
|
Industry News
Celgene, Dragonfly Expand Immunotherapy Alliance
Celgene has the option to license exclusive rights to products using Dragonfly's TriNKET platform for four new targets
11.14.18
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Evotec, Celgene in Third Discovery and Development Pact
Will leverage Evotec's Panomics platform to identify drug targets that are traditionally difficult to track
09.06.18
21 Celgene
...
07.20.18
Collaborations & Alliances
|
Drug Development
Skyhawk, Celgene in Strategic Discovery and Development Pact
To develop mRNA Splicing Modifiers using Skyhawk's STAR Technology Platform
06.26.18
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
Industry News
Evotec, Celgene Enter Oncology Partnership
Initial focus will be on solid tumors; upfront payment of $65
05.25.18
Collaborations & Alliances
|
Industry News
|
Methods Development
Abide, Celgene Enter License Agreement
For ABX-1772, a preclinical drug candidate discovered by Abide
03.28.18
Bio News
|
Collaborations & Alliances
|
Drug Delivery
|
Industry News
|
Methods Development
Amunix & Celgene Sign Licensing Agreement
For Amunix’s XTEN and ProTIA technology to augment ongoing discovery and development of therapeutics
02.20.18
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Facilities
|
Industry News
Celgene to Open Biopharma Incubator in New Jersey
The Thomas O. Daniel Research Incubator and Collaboration Center to offer entrepreneurs state-of-the-art lab space
01.19.18
Bio News
|
Breaking News
|
Industry News
Celgene to Buy Impact Biomedicines for up to $7B
Adds Fedratinib to its pipeline of novel therapies for hematologic malignancies
01.12.18
23 Celgene
...
07.24.17
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Celgene, Dragonfly Enter Strategic TriNKET Platform Pact
Aims to discover and develop Natural Killer Cell-Based Immunotherapies
06.12.17
Promotions & Moves
Executive Moves at Celgene
Smith succeeds Fouse as president and COO
02.24.17
Biologics, Proteins, Vaccines
|
Drug Development
|
Industry News
Celgene Acquires Autoimmune Biotech for $300M
Expands inflammation and immunology pipeline with purchase of Delinia
01.27.17
Collaborations & Alliances
|
Drug Development
Triphase, Celgene in Strategic ADC Alliance
Celgene has an option to acquire all Triphase assets relating to TRPH-222
12.22.16
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Celgene, PharmAkea Extend Drug Discovery Platform Pact
Will leverage discovery platform and small-molecule therapies for another nine months
11.18.16
Financial Reports
Financial Report: Celgene
Revenues up 28% in the quarter
10.28.16
Drug Discovery
24 Celgene
...
07.11.16
Promotions & Moves
Celgene Names New CEO
Alles takes over for Hugin, who’ll serve as executive chairman
01.11.16
Clinical Trials
|
Collaborations & Alliances
|
Drug Development
OncoMed Earns $72.5M Celgene Milestones
Achieves safety data and clinical candidate designation
01.05.16
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
R&D
Inception IBD, Celgene in Strategic R&D Alliance
To discover and develop therapeutics for ulcerative colitis and Crohn’s disease
12.14.15
Breaking News
|
Drug Discovery
Celgene, Nurix Target Protein Homeostasis for Next-Gen Therapies
To develop small molecule therapeutics in oncology, inflammation and immunology
09.18.15
Breaking News
|
Drug Development
|
Industry News
|
R&D
Celgene Completes Receptos Acquisition
Expands inflammation and immunology portfolio
08.28.15
Breaking News
|
Drug Discovery
|
Industry News
Celgene to Acquire Quanticel Pharmaceuticals
Celgene committed to expanding sustainable pipeline of cancer treatments
04.27.15
Breaking News
Immunome Promotes Max Rosett to Chief Financial Officer
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Johnson & Johnson Agrees to Acquire Proteologix
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
View Breaking News >
CURRENT ISSUE
May 2024
CDMOs: The Cornerstone of Biopharmaceutical Innovation
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
CEO Spotlight: Gaston Salinas
Parenteral Perspectives
The Transformative Potential of Gene Therapy
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
View More >